Dublin, April 29, 2022 (GLOBE NEWSWIRE) -- The "Global Artificial Coma/Medically Induced Coma Market Opportunity Analysis and Industry Forecast (by Drug Type, Application and Distribution Channel), 2021-2030" report has been added to ResearchAndMarkets.com's offering.
The global artificial coma/medically induced coma market was valued at $640.17 million in 2020, and is projected to reach $868.63 million by 2030, registering a CAGR of 3.1%.
An increase in the number of surgical procedures such as cosmetic surgery, brain surgery leads to a surge in usage of drugs such as propofol and barbiturate to induce coma in patients. Moreover, a growing geriatric population significantly contributes toward the market growth. A rise in production of various types of drugs to induce coma acts a key driving force of the global market.
In addition, as per the statistics provided by the American Society of Plastic Surgeons in 2019, approximately 1.8 million cases of cosmetic minimally-invasive surgeries were performed in the U.S. The application of anesthetics in general surgeries is expected to drive the growth of the market. Furthermore, increasing incidences of emergency surgeries, extensive uses of propofol and barbiturate drugs propels the growth of the market.
The global artificial coma/medically induced coma market is segmented on the basis of drug type, application, distribution channel, and region. By drug type, the market is categorized into propofol and barbiturate. By application, the market is fragmented into status epilepticus, stroke, traumatic brain injury, brain infections, drug overdose, and others. By distribution channel, the market is categorized into hospital pharmacies, drug stores & retail pharmacies and online providers. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Market dynamics
Drivers
- Escalating demand for the management of pain from geriatric population
- Increase in number of emergency surgeries
- Increase in number of drug launch and approvals
- Rising prevalence of cancer
Restraints
- Risk associated with the use of anesthetics in pediatric patients and pregnant women
- Side effects associated with anesthetics
Opportunity
- Rise in heavy investment in healthcare sector
Some of the major companies that operate in the global artificial coma/medically induced coma market are Astrazeneca Plc., B. Braun Melsungen, Baxter Healthcare Corporation, Dr. Reddy's Laboratories, Fresenius SE & CO., Hikma Pharmaceuticals, Pfizer Inc., Piramal Healthcare, Teva Pharmaceuticals Industries Ltd., and Viatris Inc.
Key Report Benefits:
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global artificial coma/medically induced coma market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- & country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Drug Type
- Propofol
- Barbiturate
By Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
By Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
KEY MARKET PLAYERS
- Astrazeneca Plc.
- B. Braun Melsungen
- Baxter Healthcare Corporation
- Dr.Reddy's Laboratories
- Fresenious SE & CO.
- Hikma Pharmaceuticals
- Pfizer Inc.
- Piramal Healthcare
- Teva Pharmaceuticals Industries Ltd.
- Viatris Inc
For more information about this report visit https://www.researchandmarkets.com/r/agjuc1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
